RHOEN-KLINIKUM AG/ DE0007042301 /
| 2020-12-30 12:00:00 AM | Chg. - | Volume | Bid10:37:07 AM | Ask1:17:50 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 16.24EUR | - | 1 Turnover: - |
-Bid Size: - | -Ask Size: - | 843.42 mill.EUR | - | 21.72 |
Assets
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 747.1000 | 852.1000 | 858.2000 | 865.6000 | 852.6000 | ||||||
| Intangible Assets | 174.5000 | 176.7000 | 178.1000 | 181.6000 | 181.6000 | ||||||
| Long-Term Investments | 38.2000 | 7.6000 | 3.3000 | 14.6000 | 19.2000 | ||||||
| Fixed Assets | 968.8000 | 1,039.5000 | 1,068.9000 | 1,063.2000 | 1,054.5000 | ||||||
| Inventories | 25 | 25.9000 | 28.4000 | 35.2000 | 33.1000 | ||||||
| Accounts Receivable | 204 | 212.4000 | 226.6000 | 193.9000 | 212.9000 | ||||||
| Cash and Cash Equivalents | 122.5000 | 132.3000 | 127.7000 | 91 | 126.3000 | ||||||
| Current Assets | 502.6000 | 549.7000 | 563 | 566.4000 | 611.1000 | ||||||
| Total Assets | 1,471.4000 | 1,589.3000 | 1,631.9000 | 1,629.7000 | 1,665.6000 | ||||||
Liabilities
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 108.2000 | 115.9000 | 84.5000 | 80.7000 | 72.5000 | ||||||
| Long-term debt | 15 | 114.7000 | 182.1000 | 165 | 166.1000 | ||||||
| Liabilities to Banks | 34.9000 | 138.6000 | 218.1000 | 180.8000 | 179.2000 | ||||||
| Provisions | 92.7000 | 62.4000 | 14 | 32.4000 | 32.2000 | ||||||
| Liabilities | 346.1000 | 454 | 470.4000 | 464.4000 | 440.8000 | ||||||
| Share Capital | 167.4060 | 167.4060 | 167.4060 | 167.4060 | 167.4060 | ||||||
| Total Equity | 1,102.3000 | 1,135.3000 | 1,161.5000 | 1,165.3000 | 1,198.3000 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 1,471.4000 | 1,589.3000 | 1,631.9000 | 1,629.7000 | 1,665.6000 | ||||||
Income Statement
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,211.1000 | 1,232.9000 | 1,303.9000 | 1,360.2000 | 1,402 | ||||||
| Depreciation (total) | 59.1000 | 60.8000 | 68.7000 | 69.4000 | 70.6000 | ||||||
| Operating Result | 38.7000 | 64.9000 | 56.8000 | 10.6000 | 30.5000 | ||||||
| Interest Income | -.2000 | -1.7000 | -2.8000 | -6.6000 | -2.7000 | ||||||
| Income Before Taxes | 37.1000 | 63.2000 | 54.2000 | 3.9000 | 27.4000 | ||||||
| Income Taxes | .4000 | 12 | 9.8000 | 1.5000 | 2.9000 | ||||||
| Minority Interests Profit | -1.6000 | -2.2000 | -1.2000 | -1 | -1.9000 | ||||||
| Net Income | 35.2000 | 49 | 43.3000 | 1.5000 | 28.3000 | ||||||
Per Share
Cash Flow
| 2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 80.3000 | 49.5000 | 47.3000 | 113.3000 | 97.5000 | ||||||
| Cash Flow from Investing Activities | -2.9000 | -125 | -86.7000 | -135.2000 | -58.3000 | ||||||
| Cash Flow from Financing | -35.7000 | 85.3000 | 35.1000 | -15.1000 | -3.9000 | ||||||
| Decrease / Increase in Cash | 41.7000 | 9.8000 | -4.3000 | -37 | 35.3000 | ||||||
| Employees | 16,688 | 16,985 | 17,687 | 18,449 | 18,227 | ||||||
